MIRSNP rs2910164 of miR-146a is associated with the muscle involvement in polymyositis/dermatomyositis

International Journal of Dermatology

Volumn 53, Issue 3, 2014, Pages 300-304

  Okada, Yoshifumi ^a   Jinnin, Masatoshi ^a   Makino, Takamitsu ^a   Kajihara, Ikko ^a   Makino, Katsunari ^a   Honda, Noritoshi ^a   Nakayama, Wakana ^a   Inoue, Kuniko ^a   Fukushima, Satoshi ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN146 MICRORNA, HUMAN;

BLOOD; DERMATOMYOSITIS; DYSPHAGIA; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PATHOLOGY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

DEGLUTITION DISORDERS; DERMATOMYOSITIS; FEMALE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

EID: 84894274369     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05739.x     Document Type: Article

References (19)

1. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999; 11: 475-482.
2. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
3. Eisenberg I, Eran A, Nishino I, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 2007; 104: 17016-17021.
4. Furer V, Greenberg JD, Attur M, et al. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 2010; 136: 1-15.
5. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007; 104: 3300-3305.
6. Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics 2007; 8: 1625-1627.
7. Mishra PJ, Banerjee D, Bertino JP. MiRSNPs or MiR- polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 2008; 7: 853-858.
8. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008; 58: 1284-1292.
9. Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007; 16: 939-946.
10. Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol 2008; 33: 312-315.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 403-407.
13. Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 2012; 33: 254-263.
14. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2012; 50: 298-301.
15. Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 2011; 61: 187-193.
16. Mishra PJ, Humeniuk R, Longo-Sorbello GS, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 2007; 104: 13513-13518.
17. Akkiz H, Bayram S, Bekar A, et al. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene 2011; 486: 104-109.
18. Shen J, Ambrosone CB, DiCioccio RA, et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008; 10: 1963-1966.
19. Nakasa T, Shibuya H, Nagata Y, et al. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 2011; 63: 1582-1590.